0 NASDAQ Companies - June 17, 20209F Inc. Reports Fourth Quarter and Full Year 2019 Unaudited Financial ResultsBEIJING, June 17, 2020 (GLOBE NEWSWIRE) — 9F Inc. (“9F” or “the Company”) (Nasdaq: JFU), a leading digital financial account […]Read More
0 NASDAQ Companies - June 17, 2020Kiniksa Announces Lancet Rheumatology Publication of Clinical Outcomes with Mavrilimumab in COVID-19HAMILTON, Bermuda, June 17, 2020 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company focused on discovering, […]Read More
0 NASDAQ Companies - June 17, 2020XpresSpa Group Announces $40 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesNEW YORK, June 17, 2020 (GLOBE NEWSWIRE) — XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”), a health and wellness […]Read More
0 NASDAQ Companies - June 17, 2020Windstream Partners with Infinera to Transmit 800G over 730 Km in Live Production Network Using ICE6 TechnologySUNNYVALE, Calif. and LITTLE ROCK, Ark., June 17, 2020 (GLOBE NEWSWIRE) — Infinera (NASDAQ: INFN) and Windstream, a leading provider […]Read More
0 NASDAQ Companies - June 17, 2020Qorvo® Takes TP-Link® Wi-Fi 6 Routers to New Levels of PerformanceGREENSBORO, N.C., June 17, 2020 (GLOBE NEWSWIRE) — Qorvo® (Nasdaq:QRVO), a leading provider of innovative RF solutions that connect the […]Read More
0 NASDAQ Companies - June 17, 2020ViralClear Opens Enrollment with First Patient Dosing in Phase II Human Trial of Anti-Viral MMPD Oral Solution for Treatment of COVID-19Westport, CT, June 17, 2020 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”) and its subsidiary, […]Read More
0 NASDAQ Companies - June 17, 2020Abeona Therapeutics Further Strengthens Board with Appointment of Two New Independent DirectorsNEW YORK and CLEVELAND, June 17, 2020 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene […]Read More
0 NASDAQ Companies - June 17, 2020Contrafect Announces Publication of Exebacase Phase 2 Study Results in the Journal of Clinical InvestigationPhase 2 study results demonstrated the potential clinical benefit of exebacase, when used in addition to existing antibiotics, for the […]Read More
0 NASDAQ Companies - June 17, 2020T2 Biosystems Regains Compliance with NASDAQ Listing RequirementsLEXINGTON, Mass., June 17, 2020 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, […]Read More
0 NASDAQ Companies - June 17, 2020Harpoon Therapeutics Updates Information for its Participation in Two Upcoming Virtual ConferencesSOUTH SAN FRANCISCO, Calif., June 17, 2020 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing […]Read More